AI-guided blood clot removal vs. standard care for brain bleeding
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study compares a new AI-guided procedure to remove blood clots from the brain with standard medical treatment. It may help people who had a stroke from high blood pressure and have a medium-sized bleed in the upper part of the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a brain bleed caused by high blood pressure, confirmed on a CT scan.
- The size of the bleed is between 20 and 50 milliliters.
- You are able to open your eyes or follow commands (GCS score of 8 or higher).
- You arrived at the hospital within 24 hours of your symptoms starting.
- You do not have another condition causing the bleed (like a tumor, blood disorder, or aneurysm).
- You do not have a severe head injury, multiple bleeds, or advanced dementia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a less invasive surgery to remove small blood clots (20–30 ml) in the basal ganglia, a deep part of the brain. It may help people who are awake but have a reduced level of consciousness after a recent brain bleed.
This trial tests a minimally invasive surgery (soft channel drainage) to remove a large blood clot deep in the brain after a stroke. It is for people who can have the procedure within 48 hours of bleeding and whose consciousness is reduced but not completely gone.
This trial uses an AI-assisted ultrasound to quickly detect brain bleeding in people with acute stroke. It may help speed up diagnosis and treatment.
This trial tests a non-invasive ultrasound device to help clear blood clots from the brain after a spontaneous bleed. It may be an option for people with small to medium-sized bleeds who do not need surgery.
This study tests a robot-assisted procedure to remove bleeding in the brain that happens after stroke treatment. The procedure uses a small tube to drain the blood, and a clot-busting drug (tenecteplase) may be injected to help break up the clot. It aims to reduce pressure in the brain and improve recovery.
This trial tests a minimally invasive procedure to remove deep brain bleeds using a special puncture guided by brain imaging, combined with a clot-dissolving drug called tenecteplase. It may help reduce damage from the bleed and improve recovery.
Hear when a new Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.